FLEQSUVY is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is Baclofen.
| Product ID | 52652-6001_9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa | 
| NDC | 52652-6001 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | FLEQSUVY | 
| Generic Name | Baclofen | 
| Dosage Form | Suspension | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-02-07 | 
| Marketing Category | NDA / | 
| Application Number | NDA215602 | 
| Labeler Name | Azurity Pharmaceuticals, Inc. | 
| Substance Name | BACLOFEN | 
| Active Ingredient Strength | 5 mg/mL | 
| Pharm Classes | GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-02-07 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0115-1010 | Baclofen | Baclofen | 
| 0115-1011 | Baclofen | Baclofen | 
| 0115-1012 | Baclofen | Baclofen | 
| 0172-4096 | Baclofen | Baclofen | 
| 0172-4097 | Baclofen | Baclofen | 
| 0527-1330 | Baclofen | baclofen | 
| 0527-1333 | Baclofen | baclofen | 
| 0527-1337 | Baclofen | baclofen | 
| 0603-2406 | Baclofen | Baclofen | 
| 0603-2407 | Baclofen | Baclofen | 
| 0615-3541 | Baclofen | Baclofen | 
| 0615-3542 | Baclofen | Baclofen | 
| 0615-8411 | Baclofen | Baclofen | 
| 0615-8412 | Baclofen | Baclofen | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  FLEQSUVY  90752265  not registered Live/Pending | Azurity Pharmaceuticals, Inc. 2021-06-03 |